We are live on ! Find out more
JSPR icon

Jasper Therapeutics
JSPR

53 hedge funds and large institutions have $82.7M invested in Jasper Therapeutics in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

4% more funds holding

Funds holding: 51 → 53 (+2)

2% more capital invested

Capital invested by funds: $81M → $82.7M (+$1.74M)

15% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 13

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
53
Holders Change
+2
Holders Change %
+3.92%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
11
Reduced
13
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Shaolin Capital Management
Florida
+$3.56M
2
KIM
Karpus Investment Management
New York
+$3.18M
3
BCM
Basso Capital Management
Connecticut
+$1.69M
4
OCAM
Owl Creek Asset Management
New York
+$1.52M
5
AFM
Anson Funds Management
Texas
+$1.38M

Top Sellers

Rank Fund Capital Flow
1
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
-$4.75M
2
UOC
UBS O'Connor
Illinois
-$4.57M
3
AIMCA
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
-$2.1M
4
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$938K
5
Goldman Sachs
Goldman Sachs
New York
-$651K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$969K +$991K +9,748 New
YCM
27
Yakira Capital Management
Connecticut
$827K – – –
EAM
28
Exos Asset Management
New York
$651K -$191K -1,881 -22%
COPPSERS
29
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$496K – – –
CCM
30
Context Capital Management
California
$495K – – –
KPF
31
K2 Principal Fund
Ontario, Canada
$470K +$483K +4,746 New
Walleye Trading
32
Walleye Trading
New York
$469K -$71.5K -703 -13%
SAM
33
Seelaus Asset Management
New Jersey
$456K +$309K +3,042 +195%
KKRC
34
Kohlberg Kravis Roberts & Co
New York
$449K +$461K +4,531 New
WC
35
Wealthspring Capital
New York
$429K – – –
SMA
36
Sage Mountain Advisors
Georgia
$353K – – –
HF
37
HRT Financial
New York
$342K -$1.02K -10 -0.3%
AA
38
AQR Arbitrage
Connecticut
$313K -$188K -1,849 -37%
CC
39
Centiva Capital
New York
$298K +$305K +3,000 New
CAPTRUST Financial Advisors
40
CAPTRUST Financial Advisors
North Carolina
$240K -$16.5K -162 -6%
OAC
41
OMERS Administration Corp
Ontario, Canada
$225K -$279K -2,739 -55%
DIG
42
DeepCurrents Investment Group
New York
$215K +$53K +521 +33%
Millennium Management
43
Millennium Management
New York
$207K +$213K +2,093 New
Citigroup
44
Citigroup
New York
$199K – – –
EIP
45
Easterly Investment Partners
Massachusetts
$198K – – –
WAM
46
Wolverine Asset Management
Illinois
$196K +$138K +1,353 +215%
VCM
47
Vivaldi Capital Management
Illinois
$150K +$154K +1,512 New
MAM
48
Marquette Asset Management
Minnesota
$134K – – –
PAM
49
Panagora Asset Management
Massachusetts
$74K – – –
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$43K +$43.8K +431 New
1
2
3

JSPR Hedge Fund Activity: Q1 2021 in Review

53 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Jasper Therapeutics (JSPR) for Q1 2021, worth a combined $82.7M — up 2.1% from $81M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new JSPR positions and 7 closed out — a net gain of 3 holders — while 11 added to existing stakes and 13 trimmed.

The largest buyer was Shaolin Capital Management, adding an estimated $3.56M. The largest seller was P. Schoenfeld Asset Management (PSAM), exiting entirely with an estimated $4.75M sold.

  • 53 institutional investors held Jasper Therapeutics (JSPR) as of Q1 2021, up from 51 in Q4 2020.
  • Funds reported $82.7M of Jasper Therapeutics stock for Q1 2021, up 2.1% quarter-over-quarter.
  • 10 funds opened new Jasper Therapeutics positions in Q1 2021 and 7 closed out, a net change of +3 holders.
  • The largest Jasper Therapeutics buyer in Q1 2021 was Shaolin Capital Management, an estimated $3.56M added.
  • The largest Jasper Therapeutics seller in Q1 2021 was P. Schoenfeld Asset Management (PSAM), an estimated $4.75M sold.

Based on aggregated 13F filings for Q1 2021.